Average Co-Inventor Count = 3.73
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (18 from 3,221 patents)
2. Genetech, Inc. (1 from 98 patents)
19 patents:
1. 12173080 - Prevention of disulfide bond reduction during recombinant production of polypeptides
2. 12145998 - Pertuzumab variants and evaluation thereof
3. 12145997 - Prevention of disulfide bond reduction during recombinant production of polypeptides
4. 12098211 - Prevention of disulfide bond reduction during recombinant production of polypeptides
5. 11999791 - Prevention of disulfide bond reduction during recombinant production of polypeptides
6. 11987637 - Prevention of disulfide bond reduction during recombinant production of polypeptides
7. 11987638 - Prevention of disulfide bond reduction during recombinant production of polypeptides
8. 11976127 - Prevention of disulfide bond reduction during recombinant production of polypeptides
9. 11639395 - Prevention of disulfide bond reduction during recombinant production of polypeptides
10. 11078294 - Prevention of disulfide bond reduction during recombinant production of polypeptides
11. 10906986 - Prevention of disulfide bond reduction during recombinant production of polypeptides
12. 10808037 - Prevention of disulfide bond reduction during recombinant production of polypeptides
13. 10759866 - Prevention of disulfide bond reduction during recombinant production of polypeptides
14. 9969811 - Pertuzumab variants and evaluation thereof
15. 9815904 - Pertuzumab variants and evaluation thereof